🔗 Share this article

The top legal official in Texas Paxton is suing the makers of acetaminophen, claiming the firms concealed safety concerns that the pain reliever created to children's neurological development.

This legal action follows thirty days after President Donald Trump advocated an unverified association between taking Tylenol - alternatively called paracetamol - during pregnancy and autism spectrum disorder in young ones.

Paxton is filing suit against the pharmaceutical giant, which once produced the medication, the exclusive pain medication approved for pregnant women, and Kenvue, which currently produces it.

In a official comment, he claimed they "misled consumers by making money from discomfort and marketing drugs ignoring the risks."

The company asserts there is lacking scientific proof linking Tylenol to autism.

"These corporations misled for generations, intentionally threatening countless individuals to increase profits," Paxton, from the Republican party, stated.

The company stated officially that it was "deeply concerned by the dissemination of inaccurate information on the reliability of acetaminophen and the potential impact that could have on the welfare of US mothers and children."

On its online platform, the company also said it had "continuously evaluated the applicable studies and there is lacking reliable evidence that indicates a established connection between taking paracetamol and autism."

Organizations representing medical professionals and medical practitioners concur.

The American College of Obstetricians and Gynecologists has declared paracetamol - the key substance in acetaminophen - is among limited choices for expectant mothers to treat pain and elevated temperature, which can present significant medical dangers if not addressed.

"In over twenty years of investigation on the consumption of paracetamol in gestation, not a single reputable study has conclusively proven that the consumption of acetaminophen in any stage of gestation leads to neurological conditions in offspring," the association commented.

The court filing references recent announcements from the former administration in arguing the medication is reportedly hazardous.

Last month, Trump generated worry from medical authorities when he told women during pregnancy to "struggle intensely" not to use Tylenol when sick.

The US Food and Drug Administration then released a statement that physicians should consider limiting the usage of Tylenol, while also stating that "a causal relationship" between the medication and autism in young ones has not been established.

Health Secretary RFK Jr, who manages the FDA, had pledged in spring to initiate "comprehensive study program" that would identify the cause of autism in a limited time.

But authorities warned that finding a unique factor of autism spectrum disorder - considered by experts to be the outcome of a intricate combination of inherited and external influences - would not be simple.

Autism spectrum disorder is a category of permanent neurological difference and condition that affects how people perceive and relate to the world, and is recognized using physician assessments.

In his lawsuit, Paxton - a Trump ally who is running for the Senate - asserts Kenvue and Johnson & Johnson "willfully ignored and attempted to silence the science" around paracetamol and autism.

The case seeks to make the corporations "remove any marketing or advertising" that asserts acetaminophen is reliable for pregnant women.

The court case parallels the complaints of a assembly of mothers and fathers of children with autism spectrum disorder and attention deficit hyperactivity disorder who filed suit against the makers of Tylenol in two years ago.

Judicial authorities dismissed the case, declaring studies from the plaintiffs' authorities was lacking definitive proof.